A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Clinical trial NCT07761117 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07761117
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction (HFpEF)Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)

Start date: 2026-08-28
Primary completion: 2029-09-03
Enrollment: 6950

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.